AIDS-related cancer diseases are malignancies with low incidence on healthy people that affect mostly subjects already immunocompromised. The connection between HIV/AIDS and these cancers has not been established yet, but a weakened immune system is certainly the main cause. We envisaged the possibility to screen a small library of compounds synthesized in our laboratory against opportunistic tumors mainly due to HIV infection like Burkitt's Lymphoma. From cellular assays and gene expression analysis we identified two promising compounds. These derivatives have the dual action required inhibiting HIV replication in human TZM-bl cells infected with HIV-1 NL4.3 and showing cytotoxic activity on human colon HT-29 and breast adenocarcinoma MCF-...
In the present work, we described the design, synthesis and biological evaluation of a novel series ...
Most drugs clinically used to suppress replication of HIV, the virus that causes AIDS, are nucleosid...
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, p...
AIDS-related cancer diseases are malignancies with low incidence on healthy people that affect mostl...
Various new classes of compounds have been recently identified as potent and selective inhibitors of...
The development of antiretroviral therapy against acquired immunodeficiency syndrome (AIDS) has been...
Several steps in the replicative cycle of human immunodeficiency virus (HIV) could be envisaged as t...
Approaches to targeting the signaling pathways responsible for tumor survival are currently under in...
Virtually all the compounds that are currently used, or under advanced clinical trial, for the treat...
Since the identification of human immunodeficiency virus (HIV) as the etiologic agent of AIDS, progr...
The possible use of HIV protease inhibitors (HIV-PI) as new therapeutic option for the treatment of ...
Novel targets for the management of HIV infection have become increasingly relevant in view of exten...
Worldwide, it is estimated that 37 million people are living with HIV/AIDS. Only 35 years ago, the ...
<p>A serious challenge in cancer treatment is to reposition the activity of various already known dr...
From our investigations the following compounds have emerged as particularly potent and selective in...
In the present work, we described the design, synthesis and biological evaluation of a novel series ...
Most drugs clinically used to suppress replication of HIV, the virus that causes AIDS, are nucleosid...
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, p...
AIDS-related cancer diseases are malignancies with low incidence on healthy people that affect mostl...
Various new classes of compounds have been recently identified as potent and selective inhibitors of...
The development of antiretroviral therapy against acquired immunodeficiency syndrome (AIDS) has been...
Several steps in the replicative cycle of human immunodeficiency virus (HIV) could be envisaged as t...
Approaches to targeting the signaling pathways responsible for tumor survival are currently under in...
Virtually all the compounds that are currently used, or under advanced clinical trial, for the treat...
Since the identification of human immunodeficiency virus (HIV) as the etiologic agent of AIDS, progr...
The possible use of HIV protease inhibitors (HIV-PI) as new therapeutic option for the treatment of ...
Novel targets for the management of HIV infection have become increasingly relevant in view of exten...
Worldwide, it is estimated that 37 million people are living with HIV/AIDS. Only 35 years ago, the ...
<p>A serious challenge in cancer treatment is to reposition the activity of various already known dr...
From our investigations the following compounds have emerged as particularly potent and selective in...
In the present work, we described the design, synthesis and biological evaluation of a novel series ...
Most drugs clinically used to suppress replication of HIV, the virus that causes AIDS, are nucleosid...
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, p...